MoosedHistory
Menu
Medical Advancements

Medical Advancements

Residency Research and the Pharmacogenomics First: The Documented Layer

The exact page text, read by your browser's voice.

Item 10 · Boundary (South Bend / Mishawaka residencies; Fort Wayne pattern) + town test

Lead: This layer is real, modest, and entirely boundary. In South Bend, the Memorial Family Medicine Residency is an unopposed 10-10-10 community program of 30 residents whose own program profiles describe research plainly and without inflation: research exists mainly as an elective and through quality-improvement and scholarly activity, “rather than a driving institutional priority.” In Mishawaka, the Saint Joseph Health System family medicine residency carries the older founding: established in 1971 and described in its program profiles as one of the nation's pioneering family medicine residencies, in a 9-9-9 structure, with each resident required to complete a family practice project; on whether a dedicated research rotation exists, its profiles conflict — one describes a research elective as available while the AMA FREIDA listing for the Mishawaka program (1201711130) records “Research rotation: Not available” — and both statements are printed here unmerged. The pharmacogenomics first the checklist points to is not in either residency and not in this town: it is Manchester University's, at Fort Wayne, which in 2016 became, in the university's own account, “the first university in the nation to offer a dedicated master's degree in pharmacogenomics,” growing from eight students in summer 2016 to 81 in fall 2021 under director David Kisor. No pharmacogenomics program, and no residency of any kind, is seated in New Carlisle; the town test for this item is a documented negative, and the residency-research layer above is carried at exactly the size its own programs claim for it — scholarly activity and required projects, not a research engine.

Sources:

  1. Memorial Hospital of South Bend family medicine residency program profiles (program 1201711129): unopposed 10-10-10, 30 residents; research as elective / QI scholarly activity, low research intensity as profiled; Beacon GME page: fellowships in Sports Medicine, Obstetrics, and Health Service Management with an Indiana University MPA.
  2. Saint Joseph Health System (Mishawaka) family medicine residency profiles (program 1201711130): established 1971, pioneering program, 9-9-9, required family practice project; research-elective description vs. AMA FREIDA “Research rotation: Not available” — conflict printed unmerged.
  3. Manchester University news, 14 Jan. 2022: “In 2016, Manchester was the first university in the nation to offer a dedicated master's degree in pharmacogenomics”; eight students summer 2016 to 81 in fall 2021; Fort Wayne campus; director David Kisor.
  4. Town test: searches for a residency or pharmacogenomics program in New Carlisle, Indiana — none found.

Cite this page

Using this page? Copy a credit line. Last updated November 12, 2026.

Source: Residency Research and the Pharmacogenomics First: The Documented Layer, Moosed History by Project Moosed, https://history.projectmoosed.com/usa/midwest/indiana/new-carlisle/medical/residency-research-and-the-pharmacogenomics-first-the-documented-layer/